Bullish
Belite Bio Initiates Rolling Submission Of New Drug Application To The U.S. Food And Drug Administration For Tinlarebant For The Treatment Of Stargardt Disease
Belite Bio has initiated a rolling submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Tinlarebant. This d...
